Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform (opens in new tab)
Broadens access to Abbott's Precision Oncology tests across more than 1,600 community cancer care centers and 4,700 providers in Flatiron's North America network, helping accelerate informed...
Read the original article